Find latest Breast videos · 500+ videos

CDK4/6 Inhibitors as First-Line Treatment for HR+, HER2- MBC

2,385 views
July 24, 2024

In this video, Dr. Joyce O’Shaughnessy shares her expertise on the standard of care first-line treatment for patients with HR+, HER2- MBC and the efficacy and safety data for CDK4/6 inhibitors in this setting.

To access additional videos and download free resources, click here.

VV-OTHR-US-DEL-3129 © 2024 Lilly USA, LLC. All Rights Reserved.

Comments are disabled for this content.